Ambulanc (Shenzhen) Tech. Co., Ltd was established in 2001 by a group of experts in emergency care. Our brand Amoul® is dedicated to innovation and the development of comprehensive life support solutions, and manufacturing respiratory therapy, cardiopulmonary resuscitation (CPR), anesthesia, emergency care, and critical care devices.
The professional R&D team plays a pivotal role in advancing technologies for pneumatic and turbine life support ventilation, CPR, airway management, conscious sedation devices, and anesthesia machines, serving healthcare professionals and patients globally.
Ambulanc owns 1000+ patents and CFDA medical device registration certificates for Class II and Class III medical equipment, besides a wide range of international certifications such as ISO13485, FDA (EUA), CE, MDL, TAG, etc. Our products are distributed across 100+ countries and regions worldwide.
-
2001SINCE
-
700+EMPLOYEES
-
20000+VALUED CUSTOMERS
-
03Amoul® Showcases Groundbreaking Emergency and ICU Innovations at the 38th Indonesia International Hospital Expo 2026The healthcare industry is rapidly evolving, with innovation improving patient outcomes. We'll showcase our advancements in respiratory and resuscitation technologies at the 38th Indonesia International Hospital Expo 2026, from October 7th to 10th at ICE in BSD City, Banten/Jakarta. As a leader in emergency and critical care solutions, Amoul® aims to aid healthcare professionals in delivering top-quality patient care.news More
English
中文
Pусский
Español
عربى
Français
Português
Deutsch






